Ligand Pharma's total assets for Q4 2024 were $941.77M, a decrease of -1.37% from the previous quarter. LGND total liabilities were $111.33M for the fiscal quarter, a -2.07% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.